Therapeutic Area Market Research Reports & Industry Analysis

The Therapeutic Area Market refers to a specific category of diseases or conditions for which there are known medical treatments or promising treatments in development. It is a way to classify drugs without reference to the type of therapy, form of action, or the company that makes it, but instead to look at the disease it treats.

Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.

Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.

...Show More ...Show Less


Therapeutic Area Industry Research & Market Reports

  • Urinary Tract Infection Treatment

    ... 2030, growing at a CAGR of 2.5% over the analysis period 2024-2030. Quinolones, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$5.2 Billion by the end ... Read More

  • Vaginal Moisturizers

    ... CAGR of 4.2% over the analysis period 2024-2030. Retail Stores, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$155.2 Million by the end of the analysis ... Read More

  • Vaginal Odor Control Product

    ... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Intimate Wash, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$3.2 Billion by the ... Read More

  • Cervical Dysplasia Diagnostics

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$793.8 Million by the end of ... Read More

  • Cartilage Degeneration Therapy

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Joint Replacements, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$7.7 Billion by the end of ... Read More

  • Constipation Treatment

    ... CAGR of 5.9% over the analysis period 2024-2030. Laxatives, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.3 Billion by the end of the analysis period. ... Read More

  • Chronic Myelogenous Leukemia Treatment

    ... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.4 Billion by ... Read More

  • Postpartum Hemorrhage (PPH) Treatment Devices

    ... Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Uterine Balloon Tamponade, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$521.7 ... Read More

  • Aesthetic Services

    ... CAGR of 7.0% over the analysis period 2024-2030. Surgical, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$17.1 Billion by the end of the analysis period. ... Read More

  • Ligament Stabilizers

    ... CAGR of 4.6% over the analysis period 2024-2030. Grade 1, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More

  • Orthopedic Braces & Support, Casting and Splints

    ... expected to reach US$10.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Orthopedic Braces & Supports, one of the segments analyzed in the report, is expected to record a ... Read More

  • Rheumatology Therapeutics

    ... CAGR of 3.2% over the analysis period 2024-2030. Disease Modifying Anti-Rheumatic Drugs (DMARDs), one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$51.3 Billion by the end ... Read More

  • Small Bone and Joint Orthopedic Devices

    ... reach US$20.4 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Fracture Fixation & Replacement Systems, one of the segments analyzed in the report, is expected to record a 7.7% ... Read More

  • Women's Health Rehabilitation Products

    ... 2030, growing at a CAGR of 1.2% over the analysis period 2024-2030. Orthopedic Rehabilitation Products, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$731.9 Million by ... Read More

  • Skin Allergy Therapeutics

    ... at a CAGR of 5.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$492.4 Million While China is Forecast to Grow at 8.3% CAGR The Skin Allergy Therapeutics market in the U.S. ... Read More

  • Retinal Implants

    ... CAGR of 7.1% over the analysis period 2024-2030. Implantable Miniature Telescope, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$34.4 Million by the end of the ... Read More

  • Sex Toys

    ... CAGR of 7.9% over the analysis period 2024-2030. Adult Vibrators, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$36.8 Billion by the end of the analysis ... Read More

  • Cancer Cachexia

    ... CAGR of 5.7% over the analysis period 2024-2030. Progestogens, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$1.5 Billion by the end of the analysis period. ... Read More

  • Hyperpigmentation Disorders Treatment

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Topical Drugs, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$3.3 Billion by the end of ... Read More

  • Neuroprotection Therapeutics

    ... CAGR of 6.9% over the analysis period 2024-2030. Free Radical Trapping Agents (Antioxidants), one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$45.7 Billion by the end ... Read More

  • Clear Aligners

    ... CAGR of 23.8% over the analysis period 2024-2030. Adult, one of the segments analyzed in the report, is expected to record a 20.5% CAGR and reach US$14.9 Billion by the end of the analysis period. ... Read More

  • Aesthetic Ophthalmology Devices

    ... at a CAGR of 7.9% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$837.6 Million by the end of ... Read More

  • Respiratory Protection Equipment

    ... at a CAGR of 6.4% over the analysis period 2024-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion by the end ... Read More

  • Intrauterine Insemination

    ... CAGR of 8.1% over the analysis period 2024-2030. The U.S. Market is Estimated at US$464.8 Million While China is Forecast to Grow at 11.7% CAGR The Intrauterine Insemination market in the U.S. is estimated at ... Read More

  • Ocular Prosthesis

    ... CAGR of 6.6% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by the end of the analysis period. ... Read More

Cookie Settings